<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0264410X22006326</prism:url><dc:identifier>doi:10.1016/j.vaccine.2022.05.037</dc:identifier><eid>1-s2.0-S0264410X22006326</eid><prism:doi>10.1016/j.vaccine.2022.05.037</prism:doi><pii>S0264-410X(22)00632-6</pii><dc:title>Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses </dc:title><prism:publicationName>Vaccine</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>fla</pubType><prism:issn>0264410X</prism:issn><prism:volume>40</prism:volume><prism:issueIdentifier>28</prism:issueIdentifier><prism:startingPage>3861</prism:startingPage><prism:endingPage>3868</prism:endingPage><prism:pageRange>3861-3868</prism:pageRange><prism:number>28</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2022-06-21</prism:coverDate><prism:coverDisplayDate>21 June 2022</prism:coverDisplayDate><prism:copyright>© 2022 Elsevier Ltd. All rights reserved.</prism:copyright><prism:publisher>Elsevier Ltd.</prism:publisher><dc:creator>Ilesanmi, Marcus M.</dc:creator><dc:creator>Adeyinka, Daniel A.</dc:creator><dc:creator>Olakunde, Babayemi O.</dc:creator><dc:description>
                  Measles remains an important cause of childhood mortality in many resource-limited countries. With Sustainable Development Goals (SDG), there has been increasing emphasis on measles vaccination as a key strategy to remarkably improve child survival. While progress has been made towards measles vaccination coverage due to SDG in some settings, there has been no prior study evaluating its impact in Nigeria. To assess the effectiveness of SDG policy implementation on measles vaccination coverage, we examined the changes in first dose of measles vaccination coverage rates among children aged 9–15 months following the implementation of SDG, and changes in spatial patterns of measles vaccination from 2014 to 2019 in Ekiti State, Southwest Nigeria. Using state and local government area-level District Health Information data from January 2014 to December 2019, we conducted interrupted time series (ITS) and spatiotemporal analyses. The ITS evaluated the immediate and continuous effects of SDG policy implementation on the monthly childhood measles vaccination coverage by comparing longitudinal changes in rates between pre-intervention period (January 2014-December 2015) and during-intervention period (January 2016-December 2019). The low and high coverage clusters across the years were detected with spatial cluster analysis. The average state-level measles vaccination coverage rates from 2014 to 2019 was 70.67%. In 2019, coverage rate was 49%—a 35.53% decline from 76% in 2014 and a state-level gap of 46%. The geographical distribution of measles vaccination varied considerably across the local government areas from 2014 to 2019. There was an initial acceleration of vaccination rates (
                        
                           
                              β
                           
                           
                              ^
                           
                        
                      = 24.07, p-value = 0.012), but a significant decrease in coverage rates after implementation of SDG policy in Ekiti State (
                        
                           
                              β
                           
                           
                              ^
                           
                        
                      = −1.08, p-value &lt; 0.001). No local government area had accelerated monthly coverage rates following SDG-implementation. Evidence suggests immediate acceleration in coverage rates which could not be sustained during SDG-era and calls for a rethink measles immunization coverage strategy in the state and other resource-limited jurisdictions to ensure vaccination scale-up.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessArticle><openaccessType/><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType/><openaccessUserLicense/><dcterms:subject>Measles</dcterms:subject><dcterms:subject>Vaccine</dcterms:subject><dcterms:subject>Sustainable Development Goals</dcterms:subject><dcterms:subject>Interrupted time series</dcterms:subject><dcterms:subject>Quasi-experiment</dcterms:subject><dcterms:subject>Spatiotemporal</dcterms:subject><dcterms:subject>Ekiti State</dcterms:subject><dcterms:subject>Resource-limited countries</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0264410X22006326" rel="self"/><link href="https://www.sciencedirect.com/science/article/pii/S0264410X22006326" rel="scidir"/></coredata><objects><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="623" height="454" size="51832">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="756" height="362" size="78666">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="756" height="359" size="71328">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="622" height="427" size="50235">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="557" height="405" size="55974">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="159" size="8355">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="105" size="9577">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="104" size="7715">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="151" size="9437">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="159" size="9754">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2757" height="2007" size="473917">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3346" height="1600" size="579935">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3346" height="1588" size="544189">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2756" height="1894" size="323208">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2466" height="1795" size="507672">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="866428">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-mmc1.pdf?httpAccept=%2A%2F%2A</object><object ref="si1" category="thumbnail" type="ALTIMG" multimediatype="Scalable Vector Graphics file" mimetype="image/svg+xml" size="2183">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-si1.svg?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="576113">https://api.elsevier.com/content/object/eid/1-s2.0-S0264410X22006326-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85130922211</scopus-id><scopus-eid>2-s2.0-85130922211</scopus-eid><pubmed-id>35644673</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/85130922211" rel="abstract"/><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271205</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291693</xocs:ssid>
         <xocs:ssid type="subj">291783</xocs:ssid>
         <xocs:ssid type="subj">291891</xocs:ssid>
         <xocs:ssid type="subj">291903</xocs:ssid>
         <xocs:ssid type="subj">291904</xocs:ssid>
         <xocs:ssid type="subj">291910</xocs:ssid>
         <xocs:ssid type="subj">291936</xocs:ssid>
         <xocs:ssid type="subj">291937</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>Vaccine</xocs:srctitle>
      <xocs:normalized-srctitle>VACCINE</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20220527">2022-05-27</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20220527">2022-05-27</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20220610">2022-06-10</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20220610">2022-06-10</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2022-06-10T22:56:09</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0264410X22006326</xocs:eid>
      <xocs:pii-formatted>S0264-410X(22)00632-6</xocs:pii-formatted>
      <xocs:pii-unformatted>S0264410X22006326</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.vaccine.2022.05.037</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0264410X22X00273</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20240405">2024-04-05T10:58:23.607334Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20220621</xocs:date-search-begin>
      <xocs:year-nav>2022</xocs:year-nav>
      <xocs:indexeddate epoch="1653619473">2022-05-27T02:44:33.972208Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issfirst issn issnnorm issuelist itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body mmlmath acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes otherkwds primabst ref</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0264-410X</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>0264410X</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>40</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>40</xocs:volume>
      </xocs:volume-list>
      <xocs:iss-first>28</xocs:iss-first>
      <xocs:issue-list>
         <xocs:issue>28</xocs:issue>
      </xocs:issue-list>
      <xocs:vol-iss-suppl-text>Volume 40, Issue 28</xocs:vol-iss-suppl-text>
      <xocs:sort-order>10</xocs:sort-order>
      <xocs:first-fp>3861</xocs:first-fp>
      <xocs:last-lp>3868</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>3861</xocs:first-page>
         <xocs:last-page>3868</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20220621</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>21 June 2022</xocs:cover-date-text>
      <xocs:cover-date-start>2022-06-21</xocs:cover-date-start>
      <xocs:cover-date-year>2022</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Regular papers</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2022 Elsevier Ltd. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>SUSTAINABLEDEVELOPMENTGOALSCHILDHOODMEASLESVACCINATIONINEKITISTATENIGERIARESULTSSPATIALINTERRUPTEDTIMESERIESANALYSES</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>ILESANMI</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>M</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Methods</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Study setting</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Data source</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Ethical consideration</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Statistical analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Temporal trend of first dose of measles vaccination coverage</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Spatial distribution of first dose of measles vaccination coverage</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Global and local spatial autocorrelations</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Changes in MCV1 before and during SDG implementation</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>CRediT authorship contribution statement</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary material</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="h0005"/>
         <xocs:ref-info refid="h0010">
            <xocs:ref-normalized-surname>PATEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2020</xocs:ref-pub-year>
            <xocs:ref-first-fp>1700</xocs:ref-first-fp>
            <xocs:ref-last-lp>1705</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0015">
            <xocs:ref-normalized-surname>BETAKOVA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>91</xocs:ref-first-fp>
            <xocs:ref-last-lp>96</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0020">
            <xocs:ref-normalized-surname>SIMONS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>2173</xocs:ref-first-fp>
            <xocs:ref-last-lp>2178</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0025"/>
         <xocs:ref-info refid="ce.other-ref_g4t_t5d_qtb"/>
         <xocs:ref-info refid="h0035"/>
         <xocs:ref-info refid="h0040"/>
         <xocs:ref-info refid="h0045"/>
         <xocs:ref-info refid="h0050">
            <xocs:ref-normalized-surname>RAINEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>8215</xocs:ref-first-fp>
            <xocs:ref-last-lp>8221</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0055">
            <xocs:ref-normalized-surname>SALAKO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>160</xocs:ref-first-fp>
            <xocs:ref-last-lp>168</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0060"/>
         <xocs:ref-info refid="h0065">
            <xocs:ref-normalized-surname>MASRESHA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>135</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0070">
            <xocs:ref-normalized-surname>ABDULRAHEEM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>194</xocs:ref-first-fp>
            <xocs:ref-last-lp>203</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>I</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0075">
            <xocs:ref-normalized-surname>OKU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0080">
            <xocs:ref-normalized-surname>AKWATAGHIBE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>392</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0085">
            <xocs:ref-normalized-surname>ADELOYE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>2871</xocs:ref-first-fp>
            <xocs:ref-last-lp>2881</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0090">
            <xocs:ref-normalized-surname>GUNNALA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>e0167835</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0095">
            <xocs:ref-normalized-surname>UTAZI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2020</xocs:ref-pub-year>
            <xocs:ref-first-fp>3062</xocs:ref-first-fp>
            <xocs:ref-last-lp>3071</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0100"/>
         <xocs:ref-info refid="h0105"/>
         <xocs:ref-info refid="h0110">
            <xocs:ref-normalized-surname>SHUAIB</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2020</xocs:ref-pub-year>
            <xocs:ref-first-fp>e002203</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0115"/>
         <xocs:ref-info refid="h0120">
            <xocs:ref-normalized-surname>HARRIS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>16</xocs:ref-first-fp>
            <xocs:ref-last-lp>23</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0125"/>
         <xocs:ref-info refid="h0130">
            <xocs:ref-normalized-surname>CUMBY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1990</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TESTINGAUTOCORRELATIONSTRUCTUREDISTURBANCESINORDINARYLEASTSQUARESINSTRUMENTALVARIABLESREGRESSIONS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="h0135"/>
         <xocs:ref-info refid="h0140"/>
         <xocs:ref-info refid="h0145"/>
         <xocs:ref-info refid="h0150"/>
         <xocs:ref-info refid="h0155">
            <xocs:ref-normalized-surname>ALMEIDA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>291</xocs:ref-first-fp>
            <xocs:ref-last-lp>302</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0160"/>
         <xocs:ref-info refid="h0165">
            <xocs:ref-normalized-surname>ANI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0170">
            <xocs:ref-normalized-surname>OLUWADARE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>49</xocs:ref-first-fp>
            <xocs:ref-last-lp>56</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0175">
            <xocs:ref-normalized-surname>OPHORI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>67</xocs:ref-first-fp>
            <xocs:ref-last-lp>75</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0180"/>
         <xocs:ref-info refid="h0185">
            <xocs:ref-normalized-surname>LO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>887</xocs:ref-first-fp>
            <xocs:ref-last-lp>892</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="h0190"/>
         <xocs:ref-info refid="h0195">
            <xocs:ref-normalized-surname>FARAG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>33</xocs:ref-first-fp>
            <xocs:ref-last-lp>52</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>ILESANMIX2022X3861</xocs:refkey3>
         <xocs:refkey4lp>ILESANMIX2022X3861X3868</xocs:refkey4lp>
         <xocs:refkey4ai>ILESANMIX2022X3861XM</xocs:refkey4ai>
         <xocs:refkey5>ILESANMIX2022X3861X3868XM</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-embargo-opening-date>2023-06-10T00:00:00.000Z</xocs:or-embargo-opening-date>
      </xocs:open-research>
      <xocs:self-archiving>
         <xocs:sa-start-date>2023-06-10T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2022 Elsevier Ltd. All rights reserved.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:third-party>
         <xocs:third-party-status>0</xocs:third-party-status>
      </xocs:third-party>
      <xocs:funding-list has-funding-info="1">
         <xocs:funding-addon-generated-timestamp>2022-06-17T05:23:14.694Z</xocs:funding-addon-generated-timestamp>
         <xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp-car</xocs:funding-addon-type>
         <xocs:funding-text>The authors would like to thank Mr. Olaoluwa Ezekiel, the Ekiti State Monitoring and Evaluation officer for Primary Health Care Development Agency for extracting the dataset from DHIS2 website.</xocs:funding-text>
      </xocs:funding-list>
      <xocs:article-sharing-framework>
         <xocs:asf-license>https://doi.org/10.15223/policy-017</xocs:asf-license>
         <xocs:asf-license>https://doi.org/10.15223/policy-037</xocs:asf-license>
         <xocs:asf-license>https://doi.org/10.15223/policy-012</xocs:asf-license>
         <xocs:asf-license>https://doi.org/10.15223/policy-029</xocs:asf-license>
         <xocs:asf-license>https://doi.org/10.15223/policy-004</xocs:asf-license>
      </xocs:article-sharing-framework>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0264-410X(22)00632-6</xocs:pii-formatted>
         <xocs:pii-unformatted>S0264410X22006326</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0264410X22006326</xocs:eid>
         <xocs:doi>10.1016/j.vaccine.2022.05.037</xocs:doi>
         <xocs:cid>271205</xocs:cid>
         <xocs:timestamp>2022-11-13T09:31:51.895858Z</xocs:timestamp>
         <xocs:cover-date-start>2022-06-21</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/MAIN/application/pdf/d84274d0a04b97deda60560f72c0717a/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>1381941</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>8</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0264410X22006326-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/PREVIEW/image/png/96e7a89f35a6d8e31f984ded44389f4b/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>57176</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr1/THUMBNAIL/image/jpeg/93b2447fb56d501e0a97381a4852d380/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>51832</xocs:filesize>
               <xocs:pixel-height>454</xocs:pixel-height>
               <xocs:pixel-width>623</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr2/DOWNSAMPLED/image/jpeg/0cb612d9b8bf264c6f62a9b85ac6c84f/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>78666</xocs:filesize>
               <xocs:pixel-height>362</xocs:pixel-height>
               <xocs:pixel-width>756</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr3/DOWNSAMPLED/image/jpeg/f929df0e1b16ac1a181482af51dfc10e/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>71328</xocs:filesize>
               <xocs:pixel-height>359</xocs:pixel-height>
               <xocs:pixel-width>756</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr4/MAIN/image/jpeg/c41b2e0112011b2b3a97d00125b4019e/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>50235</xocs:filesize>
               <xocs:pixel-height>427</xocs:pixel-height>
               <xocs:pixel-width>622</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr5/DOWNSAMPLED/image/jpeg/d2849dff4fa1d5b0ddc270eab63c5f7f/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>55974</xocs:filesize>
               <xocs:pixel-height>405</xocs:pixel-height>
               <xocs:pixel-width>557</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr1/THUMBNAIL/image/gif/9c340d682445e4dcb43964895bf16ce4/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8355</xocs:filesize>
               <xocs:pixel-height>159</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr2/THUMBNAIL/image/gif/198659fb91d4698485acc4940e548e70/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>9577</xocs:filesize>
               <xocs:pixel-height>105</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr3/THUMBNAIL/image/gif/8b936f0b64ddc36649e92cfbcdcc4d33/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7715</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr4/THUMBNAIL/image/gif/d06329079fbcfd2d0f98183421697365/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>9437</xocs:filesize>
               <xocs:pixel-height>151</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/gr5/THUMBNAIL/image/gif/bdf7d6b6f207325bbcc4ea7582814c50/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>9754</xocs:filesize>
               <xocs:pixel-height>159</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/HIGHRES/image/jpeg/9586923004d9bfb20b7620dd8ce23d71/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>473917</xocs:filesize>
               <xocs:pixel-height>2007</xocs:pixel-height>
               <xocs:pixel-width>2757</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/HIGHRES/image/jpeg/82aba028462fc17f3200dfb83d5de1ea/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>579935</xocs:filesize>
               <xocs:pixel-height>1600</xocs:pixel-height>
               <xocs:pixel-width>3346</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/HIGHRES/image/jpeg/d506d2a8b9cf3dce6906b108c3170da2/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>544189</xocs:filesize>
               <xocs:pixel-height>1588</xocs:pixel-height>
               <xocs:pixel-width>3346</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/HIGHRES/image/jpeg/2dec70dfe81195eb9fb65d4ceef15584/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>323208</xocs:filesize>
               <xocs:pixel-height>1894</xocs:pixel-height>
               <xocs:pixel-width>2756</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/HIGHRES/image/jpeg/d4414ab42206b11224ade81c5b3b3dbf/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>507672</xocs:filesize>
               <xocs:pixel-height>1795</xocs:pixel-height>
               <xocs:pixel-width>2466</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-mmc1.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/mmc1/MAIN/application/pdf/d5cde205b021ef969055b737ac454af6/mmc1.pdf</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>false</xocs:pdf-optimized>
               <xocs:filesize>866428</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-si1.svg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0264410X22006326/STRIPIN/image/svg+xml/4ebdf37e68d2b82dbbae344bbc3d5437/si1.svg</xocs:ucs-locator>
               <xocs:file-basename>si1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>si1.svg</xocs:filename>
               <xocs:extension>svg</xocs:extension>
               <xocs:filesize>2183</xocs:filesize>
               <xocs:attachment-type>ALTIMG</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0264410X22006326-am.pdf</xocs:attachment-eid>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:filesize>576113</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10N527Z494P/MAIN/application/pdf/169e06881957707b0da1810a967ed535/am.pdf</xocs:ucs-locator>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" xml:lang="en" version="5.6">
         <item-info>
            <jid>JVAC</jid>
            <aid>24031</aid>
            <ce:pii>S0264-410X(22)00632-6</ce:pii>
            <ce:doi>10.1016/j.vaccine.2022.05.037</ce:doi>
            <ce:copyright type="full-transfer" year="2022">Elsevier Ltd</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="f0005">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cn0005">
                  <ce:simple-para id="sp0010" view="all">Temporal patterns of first dose of measles vaccination in Ekiti State, Nigeria. A. annual trend B. monthly trend.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0264410X22006326/gr1" id="lk00005"/>
            </ce:figure>
            <ce:figure id="f0010">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cn0010">
                  <ce:simple-para id="sp0015" view="all">Spatial distribution of first dose of measles vaccination coverage rates of the 16 local government areas in Ekiti State, Nigeria (2014–2019).</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0264410X22006326/gr2" id="lk00010"/>
            </ce:figure>
            <ce:figure id="f0015">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="cn0015">
                  <ce:simple-para id="sp0020" view="all">Spatial distribution of relative risk of first dose of measles vaccination coverage of the 16 local government areas in Ekiti State, Nigeria (2014–2019).</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr3" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0264410X22006326/gr3" id="lk00015"/>
            </ce:figure>
            <ce:figure id="f0020">
               <ce:label>Fig. 4</ce:label>
               <ce:caption id="cn0020">
                  <ce:simple-para id="sp0025" view="all">Local spatial autocorrelation cluster maps of measles vaccination coverage rates in Ekiti State, Nigeria, 2014–2019.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr4" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0264410X22006326/gr4" id="lk00020"/>
            </ce:figure>
            <ce:figure id="f0025">
               <ce:label>Fig. 5</ce:label>
               <ce:caption id="cn0025">
                  <ce:simple-para id="sp0030" view="all">Level and trend changes of first dose of measles vaccination coverage rates in Ekiti State, Nigeria pre and post SDG-implementation (January 2014 to December 2019).</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr5" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0264410X22006326/gr5" id="lk00025"/>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" frame="topbot" id="t0005" rowsep="0" colsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cn0030">
                  <ce:simple-para id="sp0035" view="all">Global spatial autocorrelation of measles vaccination in Ekiti State, Nigeria, 2014–2019.</ce:simple-para>
               </ce:caption>
               <tgroup cols="4">
                  <colspec colname="col1" align="left"/>
                  <colspec colname="col2" align="char" char="."/>
                  <colspec colname="col3" align="char" char="."/>
                  <colspec colname="col4" align="char" char="."/>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Year</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Moran’s I index</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">z-score</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2014</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−0.331</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−1.48</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.06</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2015</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.157</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1.23</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.11</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2016</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−0.456</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−1.94</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.017</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2017</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.291</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">2.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.024</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2018</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.063</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.72</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.217</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2019</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−0.299</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">−1.23</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.099</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" frame="topbot" id="t0010" rowsep="0" colsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="cn0035">
                  <ce:simple-para id="sp0040" view="all">Effects of SDG implementation on monthly measles vaccination coverage rates among children aged 9–15 months by local government areas of Ekiti State, Nigeria, January 2014-December 2019.</ce:simple-para>
               </ce:caption>
               <tgroup cols="12">
                  <colspec colname="col1" align="left"/>
                  <colspec colname="col2" align="left"/>
                  <colspec colname="col3" align="char" char="."/>
                  <colspec colname="col4" align="left"/>
                  <colspec colname="col5" align="char" char="."/>
                  <colspec colname="col6" align="left"/>
                  <colspec colname="col7" align="char" char="."/>
                  <colspec colname="col8" align="left"/>
                  <colspec colname="col9" align="char" char="."/>
                  <colspec colname="col10" align="left"/>
                  <colspec colname="col11" align="char" char="."/>
                  <colspec colname="col12" align="left"/>
                  <thead>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" rowsep="1" role="colgroup" namest="col2" nameend="col3">Constant</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" rowsep="1" role="colgroup" namest="col4" nameend="col5">Pre-intervention slope</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" rowsep="1" role="colgroup" namest="col6" nameend="col7">Changes in level immediately after intervention</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" rowsep="1" role="colgroup" namest="col8" nameend="col9">Changes between pre- and post- intervention slopes</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" rowsep="1" role="colgroup" namest="col10" nameend="col11">Post-intervention slope</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">AR*</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <inf loc="post">0</inf>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <inf loc="post">1</inf>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <inf loc="post">2</inf>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <inf loc="post">3</inf>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <mml:math altimg="si1.svg">
                              <mml:mover accent="true">
                                 <mml:mrow>
                                    <mml:mi mathvariant="bold-italic">β</mml:mi>
                                 </mml:mrow>
                                 <mml:mrow>
                                    <mml:mo>^</mml:mo>
                                 </mml:mrow>
                              </mml:mover>
                           </mml:math>
                           <inf loc="post">4</inf>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">p-value</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Overall<br/>(Ekiti State)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">74.50<br/>69.35,79.66</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.31<br/>−0.69,0.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.119</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">24.07<br/>5.40,42.74</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.012</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.78<br/>−1.42,−0.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.019</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.08<br/>−1.61,−0.55</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">LGA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="colgroup" namest="col2" nameend="col12"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ekiti East</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">78.60<br/>61.22,95.98</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−2.32<br/>−4.30,−0.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.023</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">71.86<br/>33.62,110.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.00<br/>−1.06,3.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.336</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.32<br/>−1.86,−0.78</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ekiti South West</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">82.82<br/>68.26,97.37</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.20<br/>−0.62,1.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">
                           <br/>0.627</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">15.90<br/>−7.12,38.92</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.173</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.68<br/>−2.75,−0.60</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.003</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.48<br/>−2.17,−0.78</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ekiti West</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">81.35<br/>74.19,88.51</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.40<br/>−0.99,0.19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.182</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">19.57<br/>−4.31,43.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.107</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.81<br/>−1.71,0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.077</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.21<br/>−1.90,−0.52</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Emure</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">83.69<br/>70.04,97.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.26<br/>0.42,0.94</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.442</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">9.35<br/>−11.29,30</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.369</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.52<br/>−2.41,−0.63</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.26<br/>−1.84,−0.68</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ido−Osi</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">64.84<br/>54.96,74.73</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.15<br/>−0.35,0.66</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.548</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">31.45<br/>8.70,54.21</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.007</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.59<br/>−2.41,−0.76</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.43<br/>−2.11,−0.76</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ijero</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">67.62<br/>35.73,99.51</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.40<br/>−2.62,1.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.719</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">44.15<br/>7.17,81.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.02</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.16<br/>−3.50,1.17</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.324</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.56<br/>−2.39,−0.74</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0003</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ikere</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">85.53<br/>78.70,92.36</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.34<br/>−0.73,0.07</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">17.09<br/>−3.91,38.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.109</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.93<br/>−1.69,−0.17</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.017</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.27<br/>−1.91,−0.63</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0002</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ikole</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">79.66<br/>71.46,87.85</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.14<br/>−0.74,0.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.644</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">14.91<br/>−9.50,39.31</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.227</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.98<br/>−1.97,0.003</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.051</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.12<br/>−1.88,−0.37</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.004</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ilejemeje</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">80.75<br/>73.81,87.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.15<br/>−0.78,0.48</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.634</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">9.23<br/>−11.23,29.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.371</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.47<br/>−1.24,0.31</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.232</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.62<br/>−1.16,−0.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.025</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ise−Orun</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">54.94<br/>35.01,74.87</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.22<br/>0.02,2.43</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.046</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−7.27<br/>−26.20,11.66</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.446</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.59<br/>−2.89,−0.29</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.017</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.37<br/>−0.86,0.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.146</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Moba</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">83.23<br/>72.68,93.78</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.72<br/>−2.75,−0.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">49.76<br/>20.42,79.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.76<br/>−0.41,1.93</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.197</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.96<br/>−1.53,−0.40</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0012</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Ado</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">66.31<br/>59.84,72.77</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.45<br/>0.02,0.89</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.042</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−8.52<br/>−21.82,4.79</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.206</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.37<br/>−0.95,0.21</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.203</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.08<br/>−0.31,0.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.685</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Efon</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">74.82<br/>65.84,83.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.45<br/>−0.08,0.98</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.04<br/>−13.88,15.97</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.889</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.86<br/>−1.55,−0.18</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.015</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.41<br/>−0.85,0.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.07</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Gbonyin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">81.55<br/>68.42,94.67</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.32<br/>−2.58,−0.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.04</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">27.61<br/>−1.60,56.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.063</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.30<br/>−1.04,1.64</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.658</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.02<br/>−1.50,−0.54</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.0001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Irepodun/Ifelodun</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">75.89<br/>58.34,93.44</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.10<br/>−2.58,0.39</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.145</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">43.58<br/>14.05,73.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.004</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−0.56<br/>−2.12,0.99</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.471</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.66<br/>−2.16,−1.16</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead">Oye</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">42.85<br/>12.34,73.36</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.007</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.92<br/>−1.29,3.12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.409</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">28.71<br/>−11.81,69.23</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.169</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−2.44<br/>−4.70,−0.18</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">0.035</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">−1.52<br/>−2.05,−0.99</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">&lt;0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0045" view="all">*AR: Cumby-Huizinga test for autocorrelation.</ce:simple-para>
               </ce:legend>
            </ce:table>
         </ce:floats>
         <head>
            <ce:title id="tm005">Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses</ce:title>
            <ce:author-group id="ag005">
               <ce:author id="au005" author-id="S0264410X22006326-cd9fd6f74311789930b352873479cd38">
                  <ce:given-name>Marcus M.</ce:given-name>
                  <ce:surname>Ilesanmi</ce:surname>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
                  <ce:cross-ref refid="af005" id="c0005">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af010" id="c0010">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1" id="c0015">
                     <ce:sup loc="post">⁎</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn1" id="c0020">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au010" author-id="S0264410X22006326-dd52394cb682e214660f01172b6df808">
                  <ce:given-name>Daniel A.</ce:given-name>
                  <ce:surname>Adeyinka</ce:surname>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/software">Software</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
                  <ce:cross-ref refid="af005" id="c0025">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af015" id="c0030">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af020" id="c0035">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn1" id="c0040">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au015" author-id="S0264410X22006326-72cadd6642c99079bb93458b76b71056">
                  <ce:given-name>Babayemi O.</ce:given-name>
                  <ce:surname>Olakunde</ce:surname>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
                  <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
                  <ce:cross-ref refid="af025" id="c0045">
                     <ce:sup loc="post">e</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af030" id="c0050">
                     <ce:sup loc="post">f</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn1" id="c0055">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:affiliation id="af005" affiliation-id="S0264410X22006326-d4c731c2e61ec46abbdececb3407ce26">
                  <ce:label>a</ce:label>
                  <ce:textfn>Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Canada</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Community Health and Epidemiology</sa:organization>
                     <sa:organization>College of Medicine</sa:organization>
                     <sa:organization>University of Saskatchewan</sa:organization>
                     <sa:country>Canada</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx005">Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Canada</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="af010" affiliation-id="S0264410X22006326-fcc41e3080b4316074281f20728672fc">
                  <ce:label>b</ce:label>
                  <ce:textfn>State Primary Health Care Development Agency, Ado Ekiti, Ekiti State, Nigeria</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>State Primary Health Care Development Agency</sa:organization>
                     <sa:city>Ado Ekiti</sa:city>
                     <sa:state>Ekiti State</sa:state>
                     <sa:country>Nigeria</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx010">State Primary Health Care Development Agency, Ado Ekiti, Ekiti State, Nigeria</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="af015" affiliation-id="S0264410X22006326-89ec9ccbbbcf62ebb76a29ea8b8c36cb">
                  <ce:label>c</ce:label>
                  <ce:textfn>Saskatchewan Population Health and Evaluation Research Unit, Saskatoon, Saskatchewan, Canada</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Saskatchewan Population Health and Evaluation Research Unit</sa:organization>
                     <sa:city>Saskatoon</sa:city>
                     <sa:state>Saskatchewan</sa:state>
                     <sa:country>Canada</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx015">Saskatchewan Population Health and Evaluation Research Unit, Saskatoon, Saskatchewan, Canada</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="af020" affiliation-id="S0264410X22006326-910753312f036904739797632e2466d0">
                  <ce:label>d</ce:label>
                  <ce:textfn>Department of Public Health, Federal Ministry of Health, Abuja, Nigeria</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Public Health</sa:organization>
                     <sa:organization>Federal Ministry of Health</sa:organization>
                     <sa:city>Abuja</sa:city>
                     <sa:country>Nigeria</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx020">Department of Public Health, Federal Ministry of Health, Abuja, Nigeria</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="af025" affiliation-id="S0264410X22006326-d790a73ddfca7a70b66a1a38a8580963">
                  <ce:label>e</ce:label>
                  <ce:textfn>Department of Community Prevention and Care Services, National Agency for the Control of AIDS, Nigeria</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Community Prevention and Care Services</sa:organization>
                     <sa:organization>National Agency for the Control of AIDS</sa:organization>
                     <sa:country>Nigeria</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx025">Department of Community Prevention and Care Services, National Agency for the Control of AIDS, Nigeria</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="af030" affiliation-id="S0264410X22006326-aa3c57b2adfe7656f0f40894f060de3a">
                  <ce:label>f</ce:label>
                  <ce:textfn>Center for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu, Nigeria</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Center for Translation and Implementation Research</sa:organization>
                     <sa:organization>University of Nigeria</sa:organization>
                     <sa:city>Nsukka</sa:city>
                     <sa:state>Enugu</sa:state>
                     <sa:country>Nigeria</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="stx030">Centre for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu, Nigeria</ce:source-text>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>⁎</ce:label>
                  <ce:text>Corresponding author at: Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Canada.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Community Health and Epidemiology</sa:organization>
                     <sa:organization>College of Medicine</sa:organization>
                     <sa:organization>University of Saskatchewan</sa:organization>
                     <sa:country>Canada</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
               <ce:footnote id="fn1">
                  <ce:label>1</ce:label>
                  <ce:note-para id="np005" view="all">These authors contributed equally to this work.</ce:note-para>
               </ce:footnote>
            </ce:author-group>
            <ce:date-received day="3" month="5" year="2021"/>
            <ce:date-revised day="27" month="4" year="2022"/>
            <ce:date-accepted day="13" month="5" year="2022"/>
            <ce:abstract class="author" id="ab005" view="all"><ce:abstract-sec id="as005" view="all">
                  <ce:simple-para id="sp0005" view="all">Measles remains an important cause of childhood mortality in many resource-limited countries. With Sustainable Development Goals (SDG), there has been increasing emphasis on measles vaccination as a key strategy to remarkably improve child survival. While progress has been made towards measles vaccination coverage due to SDG in some settings, there has been no prior study evaluating its impact in Nigeria. To assess the effectiveness of SDG policy implementation on measles vaccination coverage, we examined the changes in first dose of measles vaccination coverage rates among children aged 9–15 months following the implementation of SDG, and changes in spatial patterns of measles vaccination from 2014 to 2019 in Ekiti State, Southwest Nigeria. Using state and local government area-level District Health Information data from January 2014 to December 2019, we conducted interrupted time series (ITS) and spatiotemporal analyses. The ITS evaluated the immediate and continuous effects of SDG policy implementation on the monthly childhood measles vaccination coverage by comparing longitudinal changes in rates between pre-intervention period (January 2014-December 2015) and during-intervention period (January 2016-December 2019). The low and high coverage clusters across the years were detected with spatial cluster analysis. The average state-level measles vaccination coverage rates from 2014 to 2019 was 70.67%. In 2019, coverage rate was 49%—a 35.53% decline from 76% in 2014 and a state-level gap of 46%. The geographical distribution of measles vaccination varied considerably across the local government areas from 2014 to 2019. There was an initial acceleration of vaccination rates (<mml:math altimg="si1.svg">
                        <mml:mover accent="true">
                           <mml:mrow>
                              <mml:mi mathvariant="bold-italic">β</mml:mi>
                           </mml:mrow>
                           <mml:mrow>
                              <mml:mo mathvariant="bold">^</mml:mo>
                           </mml:mrow>
                        </mml:mover>
                     </mml:math> = 24.07, p-value = 0.012), but a significant decrease in coverage rates after implementation of SDG policy in Ekiti State (<mml:math altimg="si1.svg">
                        <mml:mover accent="true">
                           <mml:mrow>
                              <mml:mi mathvariant="bold-italic">β</mml:mi>
                           </mml:mrow>
                           <mml:mrow>
                              <mml:mo mathvariant="bold">^</mml:mo>
                           </mml:mrow>
                        </mml:mover>
                     </mml:math> = −1.08, p-value &lt; 0.001). No local government area had accelerated monthly coverage rates following SDG-implementation. Evidence suggests immediate acceleration in coverage rates which could not be sustained during SDG-era and calls for a rethink measles immunization coverage strategy in the state and other resource-limited jurisdictions to ensure vaccination scale-up.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:keywords class="keyword" id="kg005" view="all">
               <ce:section-title id="st010">Keywords</ce:section-title>
               <ce:keyword id="k0005">
                  <ce:text>Measles</ce:text>
               </ce:keyword>
               <ce:keyword id="k0010">
                  <ce:text>Vaccine</ce:text>
               </ce:keyword>
               <ce:keyword id="k0015">
                  <ce:text>Sustainable Development Goals</ce:text>
               </ce:keyword>
               <ce:keyword id="k0020">
                  <ce:text>Interrupted time series</ce:text>
               </ce:keyword>
               <ce:keyword id="k0025">
                  <ce:text>Quasi-experiment</ce:text>
               </ce:keyword>
               <ce:keyword id="k0030">
                  <ce:text>Spatiotemporal</ce:text>
               </ce:keyword>
               <ce:keyword id="k0035">
                  <ce:text>Ekiti State</ce:text>
               </ce:keyword>
               <ce:keyword id="k0040">
                  <ce:text>Resource-limited countries</ce:text>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords class="abr" id="pc_uyBXI2bC8fSltm5Aay2qfn9PiOe2n7NE" view="all">
               <ce:section-title id="pc_xxEqqac9xA">Abbreviations</ce:section-title>
               <ce:keyword id="pc_wZdzph9heg">
                  <ce:text>ARC</ce:text>
                  <ce:keyword id="pc_WLgeS0FXEw">
                     <ce:text>Annual rate of change</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_MvPjuLuD2G">
                  <ce:text>CI</ce:text>
                  <ce:keyword id="pc_ybKYaXASB4">
                     <ce:text>Confidence interval</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_tW5gxwi9mg">
                  <ce:text>DHIS2</ce:text>
                  <ce:keyword id="pc_RUDPhBp3SR">
                     <ce:text>District Health Information System 2</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_41dE0JELzg">
                  <ce:text>GVAP</ce:text>
                  <ce:keyword id="pc_vYZj4RnK2p">
                     <ce:text>Global Vaccine Action Plan</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_KEvesm9N9j">
                  <ce:text>FCT</ce:text>
                  <ce:keyword id="pc_r9Ct0EUhKK">
                     <ce:text>Federal Capital Territory</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_eIXwy0PkVx">
                  <ce:text>LGA</ce:text>
                  <ce:keyword id="pc_PaP5blsDaW">
                     <ce:text>Local government area</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_PO2QnJbYNQ">
                  <ce:text>LISA</ce:text>
                  <ce:keyword id="pc_CDIQUN7yJu">
                     <ce:text>Local spatial autocorrelation</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_uoWTJwMbyd">
                  <ce:text>ITS</ce:text>
                  <ce:keyword id="pc_Tazw2pMNRA">
                     <ce:text>Interrupted time series</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_cLPhUG7vuS">
                  <ce:text>MCV</ce:text>
                  <ce:keyword id="pc_paUCYnYCaN">
                     <ce:text>Measles-containing vaccine</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_tBmHXxSfMD">
                  <ce:text>MMR</ce:text>
                  <ce:keyword id="pc_tspBJo3yTI">
                     <ce:text>Measles, mumps and rubella</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_fTxEDHp8Aq">
                  <ce:text>NHMIS</ce:text>
                  <ce:keyword id="pc_xJXexsMeOc">
                     <ce:text>National Health Management Information System</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_vdd2dSvSJm">
                  <ce:text>NICS</ce:text>
                  <ce:keyword id="pc_nYFeLwQ8B1">
                     <ce:text>National Immunization Coverage Survey</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_F3MmHHdThe">
                  <ce:text>RR</ce:text>
                  <ce:keyword id="pc_O4WqA7kCKo">
                     <ce:text>Relative risk</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_VqVItC1eGD">
                  <ce:text>SD</ce:text>
                  <ce:keyword id="pc_45p4b3WTVi">
                     <ce:text>Standard deviation</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_90Z1SopwLK">
                  <ce:text>SDG</ce:text>
                  <ce:keyword id="pc_gnfjyFro2c">
                     <ce:text>Sustainable Development Goals</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_QqB1FKJUOp">
                  <ce:text>SIA</ce:text>
                  <ce:keyword id="pc_wXUYzTvWze">
                     <ce:text>Supplementary immunization activities</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="pc_1miy55JEE2">
                  <ce:text>WHO</ce:text>
                  <ce:keyword id="pc_iIcH6dxJVY">
                     <ce:text>World Health Organization</ce:text>
                  </ce:keyword>
               </ce:keyword>
            </ce:keywords>
            <ce:data-availability id="da005" view="all">
               <ce:section-title id="st015">Data availability</ce:section-title>
               <ce:para id="p0005" view="all">The data underlying the results presented in the study are available from DHIS2 website (<ce:inter-ref xlink:href="https://dhis2nigeria.org.ng/dhis/dhis-web-dashboard/" xlink:type="simple" id="ir005">https://dhis2nigeria.org.ng/dhis/dhis-web-dashboard/#/ruVon6puq7A</ce:inter-ref>). For requests regarding this dataset, please contact the corresponding author (MMI).</ce:para>
            </ce:data-availability>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="s0005" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="st020">Introduction</ce:section-title>
                  <ce:para id="p0010" view="all">Despite being a vaccine-preventable disease, measles remains an important cause of mortality, particularly among children under 5 years of age. <ce:cross-refs refid="b0005 b0010" id="r0005">[1–2]</ce:cross-refs> In 2018, there were estimated 9,769,400 measles cases and 142,300 measles deaths worldwide. <ce:cross-ref refid="b0010" id="c0060">[2]</ce:cross-ref> With 1.8 million estimated cases in 2018, the World Health Organization (WHO) African region had the third largest measles cases globally after South-East Asia (3.8 million) and Eastern Mediterranean (2.9 million). <ce:cross-ref refid="b0010" id="c0065">[2]</ce:cross-ref> However, the African region had the highest estimated cases of measles mortality at 52,600 deaths. <ce:cross-ref refid="b0010" id="c0070">[2]</ce:cross-ref>
                  </ce:para>
                  <ce:para id="p0015" view="all">Since measles vaccine became available in 1963, <ce:cross-ref refid="b0015" id="c0075">[3]</ce:cross-ref> its widespread use has contributed to the reduction in the global burden of the disease. <ce:cross-refs refid="b0010 b0020" id="r0010">[2,4]</ce:cross-refs> In 2012, the World Health Assembly endorsed the targets in the Global Vaccine Action Plan (GVAP) of 90% national coverage and 80% for every district or equivalent administrative unit for all vaccines in national programmes by 2020. <ce:cross-ref refid="b0025" id="c0080">[5]</ce:cross-ref> In 2015, universal coverage for measles immunization (i.e., ≥95%) was also highlighted in the Sustainable Development Goals (SDG) to be implemented in 2016 and achieved by 2030. In the same vein, the Immunization Agenda 2030 (IA2030) used absence of measles cases as a benchmark for successful implementation of primary health care. <ce:cross-ref refid="b0030" id="c0085">[6]</ce:cross-ref> While measles vaccination policies and stages of implementation vary across the countries, <ce:cross-ref refid="b0035" id="c0090">[7]</ce:cross-ref> as at the end of 2019, 178 countries offered two doses of measles-containing vaccine (i.e., measles, mumps and rubella (MMR) as part of their routine immunization programs as recommended by the WHO towards elimination of measles. <ce:cross-ref refid="b0040" id="c0095">[8]</ce:cross-ref> Nonetheless, measles vaccination coverage continues to be suboptimal in many countries. In 2019, the global coverage of the first dose of measles-containing vaccine (MCV1) was 85%, whereas the coverage of the second dose (MCV2) was 71%, with wide variations across the regions and countries. <ce:cross-refs refid="b0045 b0050" id="r0015">[9–10]</ce:cross-refs> These rates were short of the GVAP targets to eliminate measles in at least five WHO regions by 2020. <ce:cross-ref refid="b0025" id="c0100">[5]</ce:cross-ref>
                  </ce:para>
                  <ce:para id="p0020" view="all">The Government of Nigeria introduced a single dose of measles vaccination into the routine national immunization program in 1979 for children aged 9 months. <ce:cross-ref refid="b0055" id="c0105">[11]</ce:cross-ref> However, this unsurprisingly was not enough to provide herd immunity, hence the continuous occurrence of fatal measles outbreaks in Nigeria. The measles endemicity in Nigeria has been attributed to low coverage of MCV1. <ce:cross-ref refid="b0060" id="c0110">[12]</ce:cross-ref> On this note, in 2006, Nigeria started intensified measles control programs, such as nationwide supplementary immunization activities (SIA), laboratory case-based surveillance and case management through human capacity building, and immunization campaigns. <ce:cross-ref refid="b0065" id="c0115">[13]</ce:cross-ref> In addition, a second dose of measles vaccination (MCV2) was implemented in 2019 for children at 18 months in Nigeria (i.e., during SDG implementation phase). Despite all these efforts, Nigeria still has one of the highest numbers of unvaccinated children and reported cases of measles per million population. <ce:cross-ref refid="b0010" id="c0120">[2]</ce:cross-ref> It is important to note that during the SDG-era nearly half of children are yet to receive the first dose of routine measles vaccination—58% in 2015 and 46% in 2019. <ce:cross-ref refid="b0060" id="c0125">[12]</ce:cross-ref> In general, vaccine hesitancy at the individual and community levels, unavailability of vaccines at scheduled times, shortage of trained providers and geographical inaccessibility to vaccination points are some of the factors that inhibit immunization coverage in Nigeria. <ce:cross-refs refid="b0070 b0075 b0080" id="r0020">[14–16]</ce:cross-refs>
                  </ce:para>
                  <ce:para id="p0025" view="all">Most of the available evidence on measles vaccine coverage in Nigeria have focused on the national- or state-level coverage, with a dearth of statewide studies reporting on local government area (LGA) level coverage and the trends. <ce:cross-ref refid="b0085" id="c0130">[17]</ce:cross-ref> It is therefore imperative that vaccination coverage at subnational levels, including LGAs are monitored to assess the progress towards the elimination of measles. In a household survey conducted in 40 districts between 2014 and 2015, Gunnala and colleagues reported that district-level measles vaccine coverage ranged widely between the districts within and across the states. <ce:cross-ref refid="b0090" id="c0135">[18]</ce:cross-ref> However, the study was limited to the high risk districts of polio in northern Nigeria, making the findings not generalizable to other parts of the country. Furthermore, a previous study that used geospatial techniques to assess subnational estimates of measles vaccine coverage from household surveys, reported that changes in estimated MCV1 coverage at the local government level between 2013 and 2016–2017 were not significant in over 95% of the LGAs. <ce:cross-ref refid="b0095" id="c0140">[19]</ce:cross-ref> However, the study suffered from small cluster-level size which in turn could have reduced the predictive power of the models. As stakeholders’ interest in achieving child-focused SDG targets by 2030 is increasing and no known published study has examined the impact of SDG policies on measles vaccination coverage in Nigeria and its states, this study was conducted to guide programmatic planning of childhood vaccination in Ekiti State. As the aggregated state and LGA-level data on MCV1 are available before and during SDG era (unlike MCV2), we examined the effectiveness of SDG policy change on childhood measles vaccination coverage rates in Ekiti State since its implementation in January 2016 using interrupted time series (ITS) modelling. Also, we used geospatial techniques to evaluate the temporal patterns of MCV1 across LGAs in Ekiti State, Nigeria.</ce:para>
               </ce:section>
               <ce:section id="s0010" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="st025">Methods</ce:section-title>
                  <ce:section id="s0015" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="st030">Study setting</ce:section-title>
                     <ce:para id="p0030" view="all">This is an analysis of historical measles vaccination (first dose) data of children aged 9–15 months which have been previously collected in Ekiti State. Apart from the Federal Capital Territory (FCT), Ekiti State is one of the 36 states in Nigeria. It is located in the southwestern region and had an estimated population of 3.3 million people in 2016, ranking 29th in the national population league table. <ce:cross-ref refid="b0100" id="c0145">[20]</ce:cross-ref> Predominantly, the state comprises of the Yoruba ethnic group. It has 16 LGAs, namely, Ado-Ekiti, Efon, Ekiti East, Ekiti South West, Ekiti West, Emure, Gbonyin, Ido-osi, Ijero, Ikere, Ikole, Ilejemeje, Irepodun/Ifelodun, Ise/Orun, Moba and Oye. Across the regions, the population ranged from 59,300 (Ilejemeje) to 427,700 (Ado Ekiti).</ce:para>
                  </ce:section>
                  <ce:section id="s0020" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="st035">Data source</ce:section-title>
                     <ce:para id="p0035" view="all">We extracted aggregate state- and LGA-level MCV1 vaccination rates from the Nigeria District Health Information System 2 (DHIS2) <ce:cross-ref refid="b0105" id="c0150">[21]</ce:cross-ref> for Ekiti State from 2014 to 2019 (monthly and annual). The DHIS2 is an open source and online health information management tool which was implemented in Nigeria in 2010 as part of the National Health Management Information System (NHMIS) for collecting and analysing routine health data. <ce:cross-ref refid="b0110" id="c0155">[22]</ce:cross-ref> The system collects health facility-level data in Nigeria to facilitate decentralized and data-driven health planning at the subnational levels. It is important to note that data quality checks—completeness, correctness, consistency and timeliness were ensured by the DHIS2 team before the data were made available for public use. <ce:cross-ref refid="b0115" id="c0160">[23]</ce:cross-ref> The outcome variable— vaccination coverage rate was pre-estimated in the DHIS2 as the percentage of children who had their MCV1 between 9 and 15 months among the population of children aged 9–15 months in Ekiti State. The choice of age-group selected for this study was informed by the Nigerian National Immunization Schedule which recommends that children should receive the first dose of measles vaccination between 9 and 15 months post delivery. Also, data from this target population are routinely reported and used to track measles coverage among children at the national and subnational levels.</ce:para>
                  </ce:section>
                  <ce:section id="s0025" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="st040">Ethical consideration</ce:section-title>
                     <ce:para id="p0040" view="all">Considering the aggregated nature of the DHIS database and no interviews with human subjects were conducted, ethical approval was not required for this study. The data extracted from DHIS database contained non-identifiable information about the children studied. Also, this study required no official request to use the secondary dataset for research purpose because DHIS2 is an open-source.</ce:para>
                  </ce:section>
                  <ce:section id="s0030" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="st045">Statistical analysis</ce:section-title>
                     <ce:para id="p0045" view="all">Data were analysed using ITS and geospatial methods. The ITS is a quasi-experimental design that is valuable in evaluating the effectiveness of intervention/policy changes from longitudinal data, when randomization is not feasible. <ce:cross-ref refid="b0120" id="c0165">[24]</ce:cross-ref> In this “natural” experiment, we evaluated the effect of SDG policy implementation on the childhood measles vaccination coverage in Ekiti State and its LGAs at a predetermined/intervention time point (i.e., January 2016). We hypothesized that SDG policy implementation would produce changes in vaccination coverage rates between January 2016 and December 2019. The change point was selected a priori based on the assumption that some changes in the vaccination coverage rates should be detected within the first month of SDG policy implementation. However, to avoid artefactual conclusions on the effects of the policy implementation, we performed sensitivity analyses in which the interruption points were shifted three months before (i.e., October, November and December 2015) and after policy implementation (i.e, February, March and April 2016). The 95% confidence intervals (CI) were estimated using Newey-West standard errors. <ce:cross-ref refid="b0125" id="c0170">[25]</ce:cross-ref>
                     </ce:para>
                     <ce:para id="p0050" view="all">We accounted for autocorrelation by estimating coverge rates at different time lags.The model fit was determined by the absence of autocorrelated errors with Cumby-Huizinga test. <ce:cross-ref refid="b0130" id="c0175">[26]</ce:cross-ref> To statistically test the changes in trend of coverage rates, Mann-Kendall and Sen’s slopes <ce:cross-ref refid="b0135" id="c0180">[27]</ce:cross-ref> were estimated. The ITS analyses were conducted using STATA software version 16.1. <ce:cross-ref refid="b0140" id="c0185">[28]</ce:cross-ref>
                     </ce:para>
                     <ce:para id="p0055" view="all">The spatiotemporal analyses were implemented in GeoDa software version 1.18. <ce:cross-ref refid="b0145" id="c0190">[29]</ce:cross-ref> To assess whether the spatial distribution of measles vaccination coverage rates are changing by location (LGAs) and time (year), we first generated Choropleth maps <ce:cross-ref refid="b0150" id="c0195">[30]</ce:cross-ref> from 2014 to 2019. In addition, yearly relative risk (RR) maps were generated using GeoDa software. The relative risk was estimated by comparing the observed coverage rate for a specified LGA to the state-level coverage (reference).</ce:para>
                     <ce:para id="p0060" view="all">At the LGA-level, a distance-based approach with a threshold of 2km was used to produce a spatial weight matrix in a geographic-coordinate shapefile of Ekiti State. To estimate spatial autocorrelation of coverage rates, we first calculated global Moran’s I index for each year. <ce:cross-ref refid="b0155" id="c0200">[31]</ce:cross-ref> The global Moran’s I provides information on spatial clusters (positive value), spatial randomness (zero) and spatial dispersion (negative value). Thereafter, we generated local spatial autocorrelation (LISA) maps to visualize clusters of LGAs with low rates across the years (i.e., low-low clusters), consistent clusters of high values (i.e. high-high clusters) as well as spatial outliers (i.e., high-low or low-high). The high-low clusters denote LGAs with relatively higher vaccination rates that were neighbors to those with relatively lower rates, and vice versa for low-high cluster. It is important to note that reference to high or low is relative to the mean of the MCV1 coverage rates. <ce:cross-ref refid="b0160" id="c0205">[32]</ce:cross-ref> For spatial autocorrelation, 999 Monte Carlo replications were performed. The significance level was set at p-value &lt; 0.05.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0035" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="st050">Results</ce:section-title>
                  <ce:section id="s0040" view="all">
                     <ce:label>3.1</ce:label>
                     <ce:section-title id="st055">Temporal trend of first dose of measles vaccination coverage</ce:section-title>
                     <ce:para id="p0065" view="all">The annual and monthly trends of MCV1 in Ekiti State are shown in <ce:cross-ref refid="f0005" id="c0210">Fig. 1</ce:cross-ref>
                        <ce:float-anchor refid="f0005"/>. The average state-level coverage rate from 2014 to 2019 was 70.67% (standard deviation (SD): 13.17%). In 2019, coverage rate was 49%—a 35.53% decline from 76% in 2014 and a state-level gap of 46% (using 95% vaccination rate for SDG-3 as a benchmark). While the annual rates showed an increased trend between 76% in 2014 and 86% in 2017 (annual rate of change (ARC) = 4.12%), measles vaccination decreased at an annual rate of 28.12%, from 86% in 2017 to 49% in 2019. Prior to SDG policy change (January 2014 to December 2015), the monthly-aggregated data showed no statistically significant trend at a monthly rate of change of 0.37% (Mann-Kendall slope = −46, Sen’s slope = −0.26, p-trend = 0.264). However, the monthly temporal trend after the policy change (January 2016 to December 2019) showed a significant monotonic downtrend at 1.66% (Mann-Kendall slope = −493, Sen’s slope = −1.07, p-trend &lt; 0.001). The vaccination coverage was lowest at 1.2% in June 2016 and peaked at 100% in December 2016. The monthly temporal changes in the coverage rates stratified by LGAs are presented in S1 Fig.</ce:para>
                  </ce:section>
                  <ce:section id="s0045" view="all">
                     <ce:label>3.2</ce:label>
                     <ce:section-title id="st060">Spatial distribution of first dose of measles vaccination coverage</ce:section-title>
                     <ce:para id="p0070" view="all">The spatial distribution and relative risk of MCV1 in Ekiti State from 2014 to 2019 are shown in <ce:cross-refs refid="f0010 f0015" id="r0025">Figs. 2 and 3</ce:cross-refs>
                        <ce:float-anchor refid="f0010"/>
                        <ce:float-anchor refid="f0015"/>, respectively. The mean coverage rate during 2014–2019 ranged from 84.67% (Efon) and 82.17% (Emure) to 60.83% (Gbonyin), with 9 LGAs recording rates below the national average. The areas below the national average during the study period were: Ekiti East (RR: 0.91), Ekiti West (RR: 0.98), Gbonyin (RR: 0.87), Idi-Osi (RR: 0.99), Ijero (RR: 0.93), Ikole (RR: 0.99), Irepodun (RR: 0.85), Moba (0.99) and Oye (RR: 0.85). Across the years, geographical distribution of measles vaccination varied considerably (<ce:cross-ref refid="f0010" id="c0215">Fig. 2</ce:cross-ref>). In 2014, no LGA attained the desired 95% universal MCV1 coverage rate, however 2 out of the 16 LGAs had at least 90% coverage (Emure and Gbonyin), while the lowest rate was recorded in Oye (51%). In 2016, the proportion of LGAs with at least 95% coverage rate increased to two (12.5%)—Ekiti East and Emure (96%). By 2019, 1 (6.25%) LGA (Efon) had reached 95% target. On the contrary, 62.5% had less than 50% of children vaccinated in 2019. As presented in <ce:cross-ref refid="f0015" id="c0220">Fig. 3</ce:cross-ref>, Efon and Emure showed consistent patterns of higher rates than the state-level average. In 2019, vaccination coverage rates were relatively higher in Efon, Emure, Moba, Ilejemeje, Ado-Ekiti and Ise-Orun, compared to the state-level average.</ce:para>
                  </ce:section>
                  <ce:section id="s0050" view="all">
                     <ce:label>3.3</ce:label>
                     <ce:section-title id="st065">Global and local spatial autocorrelations</ce:section-title>
                     <ce:para id="p0075" view="all">The global Moran’s I indices indicated random spatial patterns of MCV1 in 2016 (I = −0.5, p-value = 0.02). (<ce:cross-ref refid="t0005" id="c0225">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="t0005"/>) Also, significant geographical clustering was observed in 2017 (I = 0.3, p-value = 0.02). There was no significant spatial relationship in 2014, 2015, 2018 and 2019. The local spatial autocorrelation maps are displayed in <ce:cross-ref refid="f0020" id="c0230">Fig. 4</ce:cross-ref>
                        <ce:float-anchor refid="f0020"/>. The LISA cluster map for 2014 identified high-low spatial clusters in Ikole (I = −0.78, p-value &lt; 0.001), Ilejemeje (I = −0.48, p-value = 0.03) and Irepodun/Ifelodun (I = −0.53, p-value = 0.004). The high-low clusters were formed by the LGAs with significantly higher coverage rates than the surrounding LGAs. On the other hand, Ise/Orun had lower rates than its neighbours—low-high cluster (I = −1.59, p-value = 0.001). Based on the 2016 LISA map, Ekiti South had high-low spatial clustering (I = −2.18, p-value = 0.006). In 2017, Efon (I = 0.25, p-value = 0.036), Ekiti West (I = 0.15, p-value = 0.03) and Moba (I = 0.64, p-value = 0.04) were identified as high-high clusters (i.e., hotspots). The high-high clusters were areas that reported high vaccination rates and were surrounded by areas with similarly high rates. Also, in 2017, Emure had high rate but was surrounded by LGAs with low rates (High-Low, I = −0.21, p-value = 0.047). In 2018, Ado-Ekiti (I = 0.27, p-value = 0.04) and Irepodun/Ifelodun (I = 1.39, p-value = 0.02) were cold spots (otherwise known as low-low clusters). These two LGAs had low rates and were neighbors to areas with similarly low rates. There was no significant spatial dependence in 2015 and 2019.</ce:para>
                  </ce:section>
                  <ce:section id="s0055" view="all">
                     <ce:label>3.4</ce:label>
                     <ce:section-title id="st070">Changes in MCV1 before and during SDG implementation</ce:section-title>
                     <ce:para id="p0080" view="all">The ITS analysis shows that the baseline measles vaccination coverage rate was 74.5% in Ekiti State, ranging from 42.85% in Oye to 85.53% in Ikere before the implementation of SDG (<ce:cross-ref refid="t0010" id="c0235">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="t0010"/>). Across the LGAs, there were also different trends during implementation phase (<ce:cross-ref refid="t0010" id="c0240">Table 2</ce:cross-ref> and Appendix S2-S4 Figs). Overall, there was no significant monthly change in coverage rates prior to January 2016 (pre-implementation slope = −0.31%; 95%CI: −0.69 to 0.08%; p-value = 0.119) but a significant increase of 24.07% (95%CI: 5.40 to 42.74%, p-value = 0.012) was observed in the first month of the implementation (short-term effect). However, the long-term effects of implementation show decreasing trend in coverage rates (post-implementation slope = −1.08%; 95%CI: −1.61 to −0.55%; p-value = 0.0001) (<ce:cross-ref refid="f0025" id="c0245">Fig. 5</ce:cross-ref>
                        <ce:float-anchor refid="f0025"/>). Compared to the pre-implementation period, the coverage rate declined by −0.78% per month; 95%CI: −1.42 to −0.13%; p-value = 0.02 following implementation. As summarized in S1 Table, 18.8% of the LGAs (Ekiti East, Moba, and Gbonyin) had decelerated monthly vaccination rates before and after the policy change. For 10 LGAs (62.5%)—Ekiti South West, Ekiti West, Emure, Ido-Osi, Ijero, Ikere, Ikole, Ilejemeje, Irepodun/Ifelodun and Oye, the pre-SDG-implementation trends were not statistically significant, however, the post-implementation trend showed decreasing number of children being vaccinated for measles. Ise-Orun and Ado-Ekiti had statistically significant acceleration prior to January 2016 but remained relatively unchanged during the SDG implementation period. The trends for Efon were also constant before and after SDG implementation. No LGA had accelerated monthly coverage rates following SDG-implementation.</ce:para>
                     <ce:para id="p0085" view="all">From the sensitivity analyses (data not shown), significant trends in MCV1 rates were observed before SDG-implementation by shifting the interruption points within three months prior to the SDG-policy implementation (ranged from −0.45 to −0.59). Contrarily, later interruption points produced consistent results of no statistically significant pre-intervention trends, with an interruption point of January 2016. Also, the post-implementation trends showed declining rates of MCV1 across all the candidate interruption points, but there were somewhat no significant differences in pre- and post-implementation trends for earlier interruption dates.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0060" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="st075">Discussion</ce:section-title>
                  <ce:para id="p0090" view="all">This study determined the trend in measles vaccination coverage among children aged 9–15 months in Ekiti State, Southwest Nigeria between 2014 and 2019 taking into consideration the implementation of the SDG in the state. The main finding of this study is not only an initial acceleration of MCV1, but also a significant decrease in coverage rates after implementation of SDG policy in Ekiti State. Following SDG implementation, no LGA had accelerated monthly coverage rates. Also, we observed that coverage rates varied across the LGAs from 2014 to 2019.</ce:para>
                  <ce:para id="p0095" view="all">The two periods analyzed in this study reflect an evolution of two phases of implementation—the pre-SDG activities (2014–2015), characterized mainly by routine immunization programs, and the SDG phase (2016–2019) characterized by stronger transition to health systems reform and government re-dedication. The notable phases imply major changes; however, the trajectory of childhood measles immunization indicates a progressive reduction in coverage. Between 2014 and 2019, the geographical distribution of measles vaccination coverage varied considerably between the different LGAs of Ekiti State. Despite the fact that the SDG aimed for a universal vaccine coverage of ≥95% for adequate protection from vaccine preventable diseases, it has been a challenge for the individual LGAs within Ekiti State to attain this benchmark which cumulatively led to the suboptimal statewide coverage.</ce:para>
                  <ce:para id="p0100" view="all">Notably, only two LGAs—Ado Ekiti and Ise-Orun had increasing trend before SDG was implemented in 2016, but progress stagnated in the SDG era. While the exact reason for this unexpected finding is not known, there is tendency to maintain status quo in these areas because of the marginal progress observed at the end of 2015 (i.e., Millennium Development Goals era). Maintaining status quo in childhood vaccination efforts in Ado Ekiti and Ise-Orun is not enough to achieve the universal vaccine coverage by 2030. It is important to note that the declining trend in most LGAs (81.25%) after the policy change might make child-related SDGs unachievable in Ekiti State. Overall, measles coverage rate was lowest in June 2016 at 1.2%, and peaked at 100% in December 2016, which later dropped to 51.1% in November 2019 and to 35.9% in December 2019. The abysmally low coverage observed in June 2016 could be partly due to abruption of immunization programmes arising from statewide workers strike action. <ce:cross-ref refid="b0165" id="c0250">[33]</ce:cross-ref> Previous studies have suggested that operational challenges such as vaccine shortage, long wait at health facilities, bad road networks, and intercommunity violence partly affect uptake of childhood immunization in Ekiti State. <ce:cross-refs refid="b0170 b0175" id="r0030">[34–35]</ce:cross-refs> The low coverage rate is not peculiar to Ekiti State as the 2017 National Immunization Coverage Survey (NICS) noted a comparable rate of 42% for national measles vaccination coverage. These rates are substantially lower than the 72% observed for sub-Saharan Africa. <ce:cross-ref refid="b0180" id="c0255">[36]</ce:cross-ref> It should be noted that suboptimal immunization coverage could result in high number of measles cases which can further stress the already fragile healthcare system. <ce:cross-ref refid="b0185" id="c0260">[37]</ce:cross-ref> In 2019 alone, Ekiti State recorded 911 measles cases, out of which 60% were laboratory confirmed. <ce:cross-ref refid="b0190" id="c0265">[38]</ce:cross-ref> It is terrifying to note that most of these cases were unvaccinated children. This is a strong indication that the state is yet to achieve herd immunity because of the low measles vaccination coverage. The weak health system and social drivers of vaccine hesitancy/refusal such as myths/misinformation, distrust in vaccine and government should be addressed to increase measles vaccination.</ce:para>
                  <ce:para id="p0105" view="all">Evidence from the spatiotemporal and relative risk maps suggest that inequity in measles vaccination coverage across the LGAs is an issue. We speculate that varying stages of policy implementation and over-concentration of immunization activities in some areas might explicate the observed disparities. In addressing geographical inequities in Ekiti State and some of the programmatic challenges highlighted above, the primary healthcare needs to leverage existing community-based structures as part of the preventive healthcare agenda. The preventive healthcare agenda emphasizes the community-based strategies needed to reach the vulnerable children through home visits. <ce:cross-ref refid="b0075" id="c0270">[15]</ce:cross-ref> The competence of the extension workers and effectiveness of the strategy have not been explored in Ekiti State. Future studies on the effectiveness of community-based strategies to improve childhood vaccination uptake in Ekiti State might guide future programmes.</ce:para>
                  <ce:para id="p0110" view="all">Existing evidence suggests countries that have satisfactory health indicators invested hugely on primary healthcare and exhibited a high level of good governance. <ce:cross-ref refid="b0195" id="c0275">[39]</ce:cross-ref> It implies therefore, that effective global and national partnerships, multi-stakeholder relationships within and beyond the health sector, including the civil society and a virile healthcare system are vital for generating diverse perspectives for the SDG implementation process. Even while good policies are available, implementation is fraught with impediments and bureaucratic bottlenecks. Concerted efforts and commitments at the political level is necessary to reduce bottlenecks and enable the implementation of programmatic best-practices.</ce:para>
                  <ce:para id="p0115" view="all">To our knowledge, this study is the first to show trend as well as demonstrate the spatial distribution of measles immunization rate in Ekiti State using ecological data, to better inform macro-level planning of child health services. In addition, we employed an autoregressive ITS (a strong quasi-experimental design) which controlled for prior trends and seasonality. A clear advantage of this methodological approach is the removal of autocorrelations which could have over-fitted the models. The ITS was able to differentiate progress in the outcome variable due to the policy change into immediate/temporary and delayed/permanent changes. The sensitivity analyses further confirmed a complete separation between the pre-and post-implementation periods as the interruption points specified on or shortly after the policy implementation were driving the observed associations. However, findings from this study should be interpreted with caution as there might be concurrent child health policies during the study period. After an extensive policy review, we could not identify any policy that could have confounded the estimates either pre or post SDG implementation. Given that population-level ecological data were analysed, the findings are representative of the study area, therefore providing an unbiased reflection of the population being studied. However, inferences should be made to only the spatial units of the analysis (i.e., state and LGAs) and not to individuals. Due to unavailability of disaggregated MCV1 rates by social determinants of child health such as child sex, maternal age, education, and socioeconomic status, our study could not examine disparity in vaccination rates by social determinants of child health. Further studies aimed at assessing the impact of child health policies on health inequities and childhood vaccination is suggested.</ce:para>
                  <ce:para id="p0120" view="all">In conclusion, our results indicate that Ekiti State has not made significant progress in vaccinating children aged 9–15 months with MCV1 after the implementation of SDG policies in 2016. With coverage levels remaining below the recommended benchmark for universal coverage for SDG, Ekiti State might face serious programmatic and economic crises if measles vaccination coverage in the state is not scaled-up. The state needs to implement more impactful immunization programs to improve the current coverage rates towards achieving the SDG by 2030.</ce:para>
               </ce:section>
               <ce:section id="s6955" view="all">
                  <ce:section-title id="st98788">CRediT authorship contribution statement</ce:section-title>
                  <ce:para id="p69552" view="all">
                     <ce:bold>Marcus M. Ilesanmi:</ce:bold> Conceptualization, Methodology, Data curation, Validation, Writing – original draft, Writing – review &amp; editing. <ce:bold>Daniel A. Adeyinka:</ce:bold> Conceptualization, Methodology, Software, Formal analysis, Validation, Writing – original draft, Writing – review &amp; editing. <ce:bold>Babayemi O. Olakunde:</ce:bold> Conceptualization, Methodology, Validation, Writing – original draft, Writing – review &amp; editing.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:conflict-of-interest id="coi005" view="all">
               <ce:section-title id="st080">Declaration of Competing Interest</ce:section-title>
               <ce:para id="p0125" view="all">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</ce:para>
            </ce:conflict-of-interest>
            <ce:acknowledgment id="ak005" view="all">
               <ce:section-title id="st085">Acknowledgements</ce:section-title>
               <ce:para id="p0130" view="all">The authors would like to thank Mr. Olaoluwa Ezekiel, the Ekiti State Monitoring and Evaluation officer for Primary Health Care Development Agency for extracting the dataset from DHIS2 website.</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section view="compact-standard" id="s0065">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="st090">Supplementary material</ce:section-title>
                  <ce:para id="p0135" view="all">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="https://doi.org/10.1016/j.vaccine.2022.05.037" xlink:type="simple" id="ir010">https://doi.org/10.1016/j.vaccine.2022.05.037</ce:inter-ref>.</ce:para>
               </ce:section>
               <ce:section view="extended" id="s0070">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="st095">Supplementary material</ce:section-title>
                  <ce:para id="p0140" view="all">The following are the Supplementary data to this article:<ce:display>
                        <ce:e-component id="m0005">
                           <ce:label>Supplementary data 1</ce:label>
                           <ce:link locator="mmc1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" xlink:href="pii:S0264410X22006326/mmc1" id="lk00030"/>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="bi005" view="all">
               <ce:section-title id="st100">References</ce:section-title>
               <ce:bibliography-sec id="bs005" view="all">
                  <ce:bib-reference id="b0005">
                     <ce:label>[1]</ce:label>
                     <ce:other-ref id="h0005">
                        <ce:textref>World Health Organization. Global measles and rubella strategic plan: 2012 – 2020; 2012.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0010">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="h0010">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Patel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Goodson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Alexander</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kretsinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>Sodha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Steulet</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Progress toward regional measles elimination — worldwide, 2000–2019</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>MMWR Morb Mortal Wkly Report</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>69</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>45</sb:issue-nr>
                              <sb:date>2020</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1700</sb:first-page>
                              <sb:last-page>1705</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx035">Patel MK, Goodson JL, Alexander JP Jr, Kretsinger K, Sodha SV, Steulet C, et al. Progress Toward Regional Measles Elimination — Worldwide, 2000–2019. MMWR Morb Mortal Wkly Report. 2020;69:1700-5.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0015">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="h0015">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Betakova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Svetlikova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gocnik</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Overview of measles and mumps vaccine: origin, present, and future of vaccine production</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Acta Virol</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>57</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>91</sb:first-page>
                              <sb:last-page>96</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx040">Betakova T, Svetlikova D, Gocnik M. Overview of measles and mumps vaccine: origin, present, and future of vaccine production. Acta Virol. 2013;57(2):91-6.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0020">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="h0020">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Simons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ferrari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Fricks</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Wannemuehler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Anand</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Burton</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>The Lancet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>379</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9832</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2173</sb:first-page>
                              <sb:last-page>2178</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx045">Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. The Lancet. 2012;379(9832):2173-8.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0025">
                     <ce:label>[5]</ce:label>
                     <ce:other-ref id="h0025">
                        <ce:textref>World Health Organization. Global Vaccine Action Plan 2011 - 2020. Geneva; 2012.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0030">
                     <ce:label>[6]</ce:label>
                     <ce:other-ref id="ce.other-ref_g4t_t5d_qtb">
                        <ce:textref>WHO. Immunization Agenda 2030: A global strategy to leave no one behind; 2020</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0035">
                     <ce:label>[7]</ce:label>
                     <ce:other-ref id="h0035">
                        <ce:textref>World Health Organization(mondiale de la Santé). Measles vaccines: WHO position paper–April 2017–Note de synthèse de l’OMS sur les vaccins contre la rougeole–avril 201Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire201. p. 205–27.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0040">
                     <ce:label>[8]</ce:label>
                     <ce:other-ref id="h0040">
                        <ce:textref>World Health Organisation. Immunisation Coverage 2019 Geneva2021 [Available from: <ce:inter-ref xlink:href="https://www.who.int/news-room/fact-sheets/detail/immunization-coverage" xlink:type="simple" id="ir015">https://www.who.int/news-room/fact-sheets/detail/immunization-coverage</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0045">
                     <ce:label>[9]</ce:label>
                     <ce:other-ref id="h0045">
                        <ce:textref>Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) [Internet]; 2021 [cited Jan 20, 2021]. Available from: <ce:inter-ref xlink:href="https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles-containing-vaccine-first-dose-(mcv1)-immunization-coverage-among-1-year-olds-(-)" xlink:type="simple" id="ir020">https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles-containing-vaccine-first-dose-(mcv1)-immunization-coverage-among-1-year-olds-(-)</ce:inter-ref>.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0050">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="h0050">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Rainey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Watkins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.K.</ce:given-name>
                                 <ce:surname>Ryman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Sandhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Bo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Banerjee</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Vaccine</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>29</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>46</sb:issue-nr>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>8215</sb:first-page>
                              <sb:last-page>8221</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx050">Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009. Vaccine. 2011;29(46):8215-21.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0055">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="h0055">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Salako</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Sholeye</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Control of measles in Nigeria: A critical review of the literature</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Adv Med Med Res</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>160</sb:first-page>
                              <sb:last-page>168</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx055">Salako AA, Sholeye OO. Control of measles in Nigeria: A critical review of the Literature. Journal of Advances in Medicine and Medical Research. 2015:160-8.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0060">
                     <ce:label>[12]</ce:label>
                     <ce:other-ref id="h0060">
                        <ce:textref>World Health Organisation. WHO vaccine-preventable diseases: monitoring system. 2020 global summary - WHO UNICEF estimate time series for Nigeria 2021 [Available from: <ce:inter-ref xlink:href="https://apps.who.int/immunization_monitoring/globalsummary/estimates?c=NGA" xlink:type="simple" id="ir025">https://apps.who.int/immunization_monitoring/globalsummary/estimates?c=NGA</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0065">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="h0065">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Masresha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Braka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Onwu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Oteri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Erbeto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Oladele</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Progress towards measles elimination in Nigeria: 2012 - 2016</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Immunological Sci</sb:maintitle>
                                 </sb:title>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>135</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx060">Masresha B, Braka F, Onwu NU, Oteri J, Erbeto T, Oladele S, et al. Progress towards measles elimination in Nigeria: 2012–2016. Journal of immunological sciences. 2018:135.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0070">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="h0070">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Abdulraheem</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Onajole</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Jimoh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Oladipo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Public Health Epidemiol</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>4</sb:issue-nr>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>194</sb:first-page>
                              <sb:last-page>203</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx065">Abdulraheem I, Onajole A, Jimoh A, Oladipo A. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. Journal of Public Health and Epidemiology. 2011;3(4):194-203.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0075">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="h0075">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Oku</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Oyo-Ita</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Glenton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Fretheim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Eteng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Ames</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>BMC Public Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <ce:doi>10.1186/s12889-017-4020-6</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx070">Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H, et al. Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study. BMC public health. 2017;17(1):1-12.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0080">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="h0080">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.N.</ce:given-name>
                                 <ce:surname>Akwataghibe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Ogunsola</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.W.</ce:given-name>
                                 <ce:surname>Broerse</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.A.</ce:given-name>
                                 <ce:surname>Popoola</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.I.</ce:given-name>
                                 <ce:surname>Agbo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Dieleman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Exploring factors influencing immunization utilization in Nigeria-A mixed methods study</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Front Public Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>392</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx075">Akwataghibe NN, Ogunsola EA, Broerse JEW, Popoola OA, Agbo AI, Dieleman MA. Exploring Factors Influencing Immunization Utilization in Nigeria-A Mixed Methods Study. Front Public Health. 2019;7:392.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0085">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="h0085">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Adeloye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Jacobs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.O.</ce:given-name>
                                 <ce:surname>Amuta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Ogundipe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Mosaku</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Gadanya</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Coverage and determinants of childhood immunization in Nigeria: a systematic review and meta-analysis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Vaccine</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>35</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>22</sb:issue-nr>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2871</sb:first-page>
                              <sb:last-page>2881</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx080">Adeloye D, Jacobs W, Amuta AO, Ogundipe O, Mosaku O, Gadanya MA, et al. Coverage and determinants of childhood immunization in Nigeria: a systematic review and meta-analysis. Vaccine. 2017;35(22):2871-81.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0090">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="h0090">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Gunnala</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.U.</ce:given-name>
                                 <ce:surname>Ogbuanu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.J.</ce:given-name>
                                 <ce:surname>Adegoke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Scobie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.V.</ce:given-name>
                                 <ce:surname>Uba</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.A.</ce:given-name>
                                 <ce:surname>Wannemuehler</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Routine vaccination coverage in northern nigeria: results from 40 district-level cluster surveys, 2014–2015</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS ONE</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>12</sb:issue-nr>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e0167835</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx085">Gunnala R, Ogbuanu IU, Adegoke OJ, Scobie HM, Uba BV, Wannemuehler KA, et al. Routine vaccination coverage in northern nigeria: results from 40 district-level cluster surveys, 2014-2015. PloS one. 2016;11(12):e0167835.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0095">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="h0095">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.E.</ce:given-name>
                                 <ce:surname>Utazi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wagai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Pannell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.T.</ce:given-name>
                                 <ce:surname>Cutts</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.A.</ce:given-name>
                                 <ce:surname>Rhoda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Ferrari</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Vaccine</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>38</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>14</sb:issue-nr>
                              <sb:date>2020</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3062</sb:first-page>
                              <sb:last-page>3071</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx090">Utazi CE, Wagai J, Pannell O, Cutts FT, Rhoda DA, Ferrari MJ, et al. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys. Vaccine. 2020;38(14):3062-71.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0100">
                     <ce:label>[20]</ce:label>
                     <ce:other-ref id="h0100">
                        <ce:textref>National Bureau of Statistics. Demographic Statistics Bulletin; 2017. p. 1-26.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0105">
                     <ce:label>[21]</ce:label>
                     <ce:other-ref id="h0105">
                        <ce:textref>DHIS. District health information system, version 2; 2019 [Available from: <ce:inter-ref xlink:href="https://www.dhis2.org/" xlink:type="simple" id="ir030">https://www.dhis2.org/</ce:inter-ref>.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0110">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="h0110">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Shuaib</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.B.</ce:given-name>
                                 <ce:surname>Garba</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Meribole</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Obasi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Sule</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Nnadi</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Implementing the routine immunisation data module and dashboard of DHIS2 in Nigeria, 2014–2019</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>BMJ Global Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>7</sb:issue-nr>
                              <sb:date>2020</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e002203</sb:first-page>
                           </sb:pages>
                           <ce:doi>10.1136/bmjgh-2019-002203</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx095">Shuaib F, Garba AB, Meribole E, Obasi S, Sule A, Nnadi C, et al. Implementing the routine immunisation data module and dashboard of DHIS2 in Nigeria, 2014–2019. BMJ global health. 2020;5(7):e002203.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0115">
                     <ce:label>[23]</ce:label>
                     <ce:other-ref id="h0115">
                        <ce:textref>DHIS2.org. Control Data Quality; 2021.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0120">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="h0120">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Harris</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>McGregor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.N.</ce:given-name>
                                 <ce:surname>Perencevich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Furuno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Peterson</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The use and interpretation of quasi-experimental studies in medical informatics</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Am Med Inform Assoc</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>16</sb:first-page>
                              <sb:last-page>23</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx100">Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson DE, et al. The use and interpretation of quasi-experimental studies in medical informatics. Journal of the American Medical Informatics Association. 2006;13(1):16-23.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0125">
                     <ce:label>[25]</ce:label>
                     <ce:other-ref id="h0125">
                        <ce:textref>StataCorp LLC. Regression with Newey-West stndard errors; 2021.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0130">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="h0130">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.E.</ce:given-name>
                                 <ce:surname>Cumby</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Huizinga</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Testing the autocorrelation structure of disturbances in ordinary least squares and instrumental variables regressions</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>1990</sb:date>
                              <sb:publisher>
                                 <sb:name>National Bureau of Economic Research Cambridge</sb:name>
                                 <sb:location>Mass., USA</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx105">Cumby RE, Huizinga J. Testing the autocorrelation structure of disturbances in ordinary least squares and instrumental variables regressions. National Bureau of Economic Research Cambridge, Mass., USA; 1990.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0135">
                     <ce:label>[27]</ce:label>
                     <ce:other-ref id="h0135">
                        <ce:textref>Thorsten Pohlert. Non-Parametric Trend Tests and Change-Point Detection; 2020.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0140">
                     <ce:label>[28]</ce:label>
                     <ce:other-ref id="h0140">
                        <ce:textref>StataCorp LLC. Stata version 16.1; 2019 [Available from: <ce:inter-ref xlink:href="https://www.stata.com/+order/" xlink:type="simple" id="ir035">https://www.stata.com/ order/</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0145">
                     <ce:label>[29]</ce:label>
                     <ce:other-ref id="h0145">
                        <ce:textref>Anselin L. GeoDa on Github [Available from: <ce:inter-ref xlink:href="https://geodacenter.github.io/download_windows.html" xlink:type="simple" id="ir040">https://geodacenter.github.io/download_windows.html</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0150">
                     <ce:label>[30]</ce:label>
                     <ce:other-ref id="h0150">
                        <ce:textref>GeoDa. An Introduction to Spatial Data Science - Basic Mapping 2020 [Available from: <ce:inter-ref xlink:href="https://geodacenter.github.io/workbook/3a_mapping/lab3a.html" xlink:type="simple" id="ir045">https://geodacenter.github.io/workbook/3a_mapping/lab3a.html</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0155">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="h0155">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.A.d.</ce:given-name>
                                 <ce:surname>Almeida</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Coutinho</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.D.M.</ce:given-name>
                                 <ce:surname>Esquerdo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Adami</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Venturieri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.G.</ce:given-name>
                                 <ce:surname>Diniz</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>High spatial resolution land use and land cover mapping of the Brazilian Legal Amazon in 2008 using Landsat-5/TM and MODIS data</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Acta Amazonica</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>46</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>291</sb:first-page>
                              <sb:last-page>302</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx110">Almeida CAd, Coutinho AC, Esquerdo JCDM, Adami M, Venturieri A, Diniz CG, et al. High spatial resolution land use and land cover mapping of the Brazilian Legal Amazon in 2008 using Landsat-5/TM and MODIS data. Acta Amazonica. 2016;46:291-302.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0160">
                     <ce:label>[32]</ce:label>
                     <ce:other-ref id="h0160">
                        <ce:textref>GeoDa. An Introduction to Spatial Data Science-Local Spatial Autocorrelation (1) 2020 [Available from: <ce:inter-ref xlink:href="https://geodacenter.github.io/workbook/6a_local_auto/lab6a.html" xlink:type="simple" id="ir050">https://geodacenter.github.io/workbook/6a_local_auto/lab6a.html</ce:inter-ref>].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0165">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="h0165">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ani</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Industrial action: Fayose declares indefinite strike in solidarity with workers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Daily Post</sb:maintitle>
                                 </sb:title>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx115">Emmanuel Ani. Industrial action: Fayose declares indefinite strike in solidarity with workers. Daily Post. 2016.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0170">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="h0170">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Oluwadare</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The social determinants of routine immunisation in Ekiti State of Nigeria</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Stud Ethno-Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>49</sb:first-page>
                              <sb:last-page>56</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx120">Oluwadare C. The social determinants of routine immunisation in Ekiti State of Nigeria. Studies on Ethno-Medicine, 2009. 2009;3(1):49-56.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0175">
                     <ce:label>[35]</ce:label>
                     <sb:reference id="h0175">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Ophori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.Y.</ce:given-name>
                                 <ce:surname>Tula</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.V.</ce:given-name>
                                 <ce:surname>Azih</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Okojie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.E.</ce:given-name>
                                 <ce:surname>Ikpo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Current trends of immunization in Nigeria: prospect and challenges</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Trop Med Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>42</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>67</sb:first-page>
                              <sb:last-page>75</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx125">Ophori EA, Tula MY, Azih AV, Okojie R, Ikpo PE. Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health. 2014;42(2):67-75.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0180">
                     <ce:label>[36]</ce:label>
                     <ce:other-ref id="h0180">
                        <ce:textref>NICS. National Immunization Coverage Survey Brief-Nigeria; 2017.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0185">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="h0185">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Lo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Hotez</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Public health and economic consequences of vaccine hesitancy for measles in the United States</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>JAMA Pediatr</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>171</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9</sb:issue-nr>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>887</sb:first-page>
                              <sb:last-page>892</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx130">Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017;171(9):887-92.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0190">
                     <ce:label>[38]</ce:label>
                     <ce:other-ref id="h0190">
                        <ce:textref>Measles Monthly Situation Report In Nigeria Epi-Week 49 - 52 [Internet]. Nigeria Centre For Disease Control; 2019 [cited January 29, 2021].</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="b0195">
                     <ce:label>[39]</ce:label>
                     <sb:reference id="h0195">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Farag</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Nandakumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wallack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Hodgkin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Gaumer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Erbil</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Health expenditures, health outcomes and the role of good governance</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int J Health Care Finance Econ</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>33</sb:first-page>
                              <sb:last-page>52</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="stx135">Farag M, Nandakumar AK, Wallack S, Hodgkin D, Gaumer G, Erbil C. Health expenditures, health outcomes and the role of good governance. Int J Health Care Finance Econ. 2013;13(1):33-52.</ce:source-text>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>